Israel China Biotechnology (ICB) Ltd (TA:ICB) — Stock Price
Israel China Biotechnology (ICB) Ltd (TA:ICB) is currently trading at ILA4365.00 ILA, up 3.93% today. Over the past 52 weeks, shares have ranged between ILA200.00 and ILA4858.00. This page tracks Israel China Biotechnology (ICB) Ltd's live share price on the TA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see ICB stock market capitalisation.
Israel China Biotechnology (ICB) Ltd (ICB) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Israel China Biotechnology (ICB) Ltd's daily closing share price and trading volume on the TA exchange over the past year, giving a clear view of recent price momentum and liquidity.
Israel China Biotechnology (ICB) Ltd Income Statement — Revenue, Profit & Earnings by Year
Israel China Biotechnology (ICB) Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|
| Total Revenue | ILA83.00K | ILA139.00K | ILA105.00K | ILA64.00K | ILA96.00K |
| Cost of Revenue | ILA307.00K | ILA0.00 | ILA0.00 | ILA227.00K | ILA227.00K |
| Gross Profit | ILA-224.00K | ILA139.00K | ILA105.00K | ILA-163.00K | ILA-131.00K |
| Research & Development | ILA627.00K | ILA1.05 Million | ILA249.00K | ILA1.72 Million | ILA2.27 Million |
| SG&A | ILA1.20 Million | ILA1.52 Million | ILA1.60 Million | ILA839.00K | ILA561.00K |
| Total Operating Expenses | ILA5.38 Million | ILA6.04 Million | ILA4.03 Million | ILA3.70 Million | ILA3.93 Million |
| Operating Income | ILA-5.29 Million | ILA-5.90 Million | ILA-3.93 Million | ILA-3.64 Million | ILA-3.83 Million |
| EBITDA | ILA-11.16 Million | ILA-5.64 Million | ILA-3.53 Million | ILA-3.40 Million | — |
| EBIT | ILA-5.29 Million | ILA-5.96 Million | ILA-3.93 Million | ILA-3.64 Million | ILA-3.58 Million |
| Interest Expense | ILA0.00 | ILA0.00 | ILA0.00 | ILA0.00 | ILA0.00 |
| Income Before Tax | ILA-11.93 Million | ILA-6.42 Million | ILA-3.62 Million | ILA-3.66 Million | ILA-3.85 Million |
| Income Tax Expense | — | ILA-10.00K | ILA7.00K | — | — |
| Net Income | ILA-11.93 Million | ILA-6.41 Million | ILA-3.62 Million | ILA-3.66 Million | ILA-3.85 Million |
Israel China Biotechnology (ICB) Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Israel China Biotechnology (ICB) Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|
| Total Assets | ILA8.34 Million | ILA11.57 Million | ILA9.88 Million | ILA1.18 Million | ILA4.06 Million |
| Total Current Assets | ILA2.13 Million | ILA4.41 Million | ILA5.79 Million | ILA1.13 Million | ILA3.66 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | ILA47.00K | ILA39.00K | ILA6.00K | ILA26.00K | ILA111.00K |
| Inventory | — | — | — | — | — |
| Property, Plant & Equipment | ILA2.01 Million | ILA2.73 Million | ILA306.00K | ILA47.00K | ILA72.00K |
| Goodwill | — | — | — | — | — |
| Total Liabilities | ILA7.87 Million | ILA9.68 Million | ILA2.46 Million | ILA2.87 Million | ILA2.15 Million |
| Total Current Liabilities | ILA6.59 Million | ILA7.36 Million | ILA1.21 Million | ILA1.05 Million | ILA344.00K |
| Long-term Debt | — | — | — | — | — |
| Net Debt | — | — | — | — | — |
| Total Stockholder Equity | ILA470.00K | ILA1.89 Million | ILA7.41 Million | ILA-1.69 Million | ILA1.91 Million |
| Retained Earnings | ILA-97.89 Million | ILA-85.96 Million | ILA-79.56 Million | ILA-75.93 Million | ILA-72.27 Million |
Israel China Biotechnology (ICB) Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Israel China Biotechnology (ICB) Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|
| Operating Cash Flow | ILA-4.34 Million | ILA-4.22 Million | ILA-4.75 Million | ILA-3.17 Million | ILA-3.94 Million |
| Capital Expenditures | ILA8.00K | ILA6.00K | ILA319.00K | ILA319.00K | ILA5.00K |
| Free Cash Flow | ILA-4.35 Million | ILA-4.23 Million | ILA-5.07 Million | ILA-3.17 Million | — |
| Investing Cash Flow | ILA-2.00 Million | ILA-2.15 Million | ILA-2.89 Million | ILA-2.89 Million | ILA-5.00K |
| Financing Cash Flow | ILA5.50 Million | ILA3.87 Million | ILA11.85 Million | ILA696.00K | ILA9.00K |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | ILA730.00K | ILA725.00K | ILA26.00K | ILA25.00K | ILA250.00K |
| Change in Cash | ILA-834.00K | ILA-2.79 Million | ILA4.73 Million | ILA-2.47 Million | ILA-3.96 Million |
Israel China Biotechnology (ICB) Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Israel China Biotechnology (ICB) Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for Israel China Biotechnology (ICB) Ltd.